Literature DB >> 2445665

Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

E Kita1, M Emoto, N Katsui, K Nishi, K Yasui, K Yasui, S Kashiba.   

Abstract

The active component in crude ribosomal fraction (CRF) of Salmonella typhimurium, capable of inducing protective antibody, was partially purified by two series of chromatography (Sephadex G-150 and DEAE-Sepharose CL6B) after sodium dodecyl sulphate (SDS)-treated CRF was precipitated with ammonium sulphate. The major active component was eluted by 0.4-0.45 M NaCl from DEAE-Sepharose CL6B, and its molecular weight was 43,000 as determined by SDS-polyacrylamide gel electrophoresis. Immunization with the fraction containing 43,000 component alone did not always confer protection on CF1 mice, but its administration together with either the purified transfer RNA (tRNA) or Freund's complete adjuvant (FCA) was much more effective against infection with S. typhimurium. Antibody to the fraction containing 43,000 component was not only free in serum but also associated with peritoneal cells. Macrophages that had been exposed to the antibody had enhanced anti-bacterial activity. Western blot analysis showed that 43,000 component did not react to antiserum to lipopolysaccharide (LPS), but to antiserum to CRF. The antibody elicited by non-O antigenic component and the cell-mediated resistance stimulated by the adjuvant effect of RNA together confer effective protection on CF1 mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445665      PMCID: PMC1453966     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice.

Authors:  J Plant; A A Glynn
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoeae.

Authors:  M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Characterization of "clearance" factor and "cell-bound" antibody in experimental typhoid.

Authors:  D Ushiba; T Nakae; T Akiyama; Y Kishimoto
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

5.  Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

6.  Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.

Authors:  E Kita; M Emoto; K Yasui; K Yasui; N Katsui; K Nishi; S Kashiba
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

8.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. I. Requirement of the antibody to non-O antigen for protection in mice that are not protected by the RNA-rich vaccine.

Authors:  E Kita; K Nishi; M Emoto; N Katsui; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

9.  Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro.

Authors:  C R Lissner; R N Swanson; A D O'Brien
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

10.  Host-parasite relations in mouse typhoid.

Authors:  G B Mackaness; R V Blanden; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.